Anupam Rasayan India Limited , a leading specialty chemicals company, has announced the appointment of Mr. Milind Madan Talathi as an Additional Director, categorized as Non-Executive Independent Director, for a three-year term. This strategic move, approved by the company's Board of Directors, aims to bring extensive industry experience to its leadership team.

Appointment Details

The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, approved Talathi's appointment for a term spanning from September 25, 2025, to September 24, 2028. This appointment is subject to shareholder approval at the upcoming general meeting.

Expertise and Background

Mr. Talathi brings a wealth of experience to Anupam Rasayan, with a career spanning around four decades in the chemical manufacturing sector. His expertise covers a wide range of areas, including:

• Operations management
• Environmental Health and Safety (EHS)
• Human Resources and Industrial Relations
• Innovation and Supply Chain Management
• Regulatory liaison

Talathi's educational background includes:

• A degree in Chemical Engineering from UDCT Mumbai
• A Management degree from Pune University
• Additional courses from prestigious institutions like IIM-A and TMTC

Professional Journey

Throughout his illustrious career, Mr. Talathi has held several leadership positions in renowned companies:

• Started his career with Tata Group's Rallis India Ltd. in Chandigarh
• Served as President (Operations) at Century Enka Ltd. for their Pune & Mahad sites
• Held the position of COO at Gujarat Fluorochemicals in Dahej
• Appointed as Whole Time Director at ELANTAS Beck India Ltd., part of the ALTANA GmbH Group

Additional Responsibilities

In addition to his role as an Independent Director, Talathi will also join Anupam Rasayan's Risk Management Committee, effective from his appointment date.

Industry Involvement

Mr. Talathi is actively involved in various industry and community roles:

• Chairman of the Chemical Sector Vertical at MCCIA
• Member of the Start-up Advisory Council at MIT-TBI
• Mentor to several entrepreneurs
• Engaged with the UDCT Alumni Association and the Indian Institute of Chemical Engineers
• Associated with Lions Club of Pune, Sahakarnagar

Compliance and Independence

The company has confirmed that Mr. Talathi meets the independence criteria as prescribed under the Companies Act, 2013 and SEBI Listing Regulations. Furthermore, he is not related to any existing directors of Anupam Rasayan India Limited.

This appointment underscores Anupam Rasayan's commitment to strengthening its board with experienced professionals, potentially enhancing its strategic decision-making capabilities in the competitive specialty chemicals market.

Anupam Rasayan India Limited , a leading custom synthesis and specialty chemical player, has announced significant expansions in its long-term contracts and reported robust financial results for the first quarter of fiscal year 2026.

Contract Expansions and Sustainable Growth

The company has successfully expanded its long-term contracts with global leaders in the agrochemical and specialty chemical sectors. This strategic move aligns with Anupam Rasayan's commitment to sustainable growth and strengthening its position in the global market.

As part of its growth strategy, the company is incorporating value-added molecules into its operations. This initiative is expected to enhance its product portfolio and cater to the evolving needs of its global clientele.

Anupam Rasayan is also making substantial investments in eco-friendly processes, underscoring its dedication to sustainable practices in the chemical industry. These investments are likely to improve the company's environmental footprint while meeting the increasing demand for environmentally responsible chemical solutions.

Strong Financial Performance in Q1 FY26

The company's financial results for the quarter ended June 30, 2025, reflect significant growth:

• Consolidated total revenue stood at ₹4,907.00 million, marking an impressive year-on-year growth of 89%.
• EBITDA (including other income) reached ₹1,292.00 million, up by 118% compared to the same quarter last year.
• Profit After Tax (PAT) surged to ₹485.00 million, representing a substantial increase of 297% year-on-year.

Key Financial Highlights

The EBITDA margin for Q1 FY26 stood at an impressive 26%, indicating strong operational efficiency.

Management Commentary

Mr. Anand Desai, Managing Director of Anupam Rasayan, commented on the performance: "We strongly believe that the sectoral trends are in our favor, and we are witnessing a clear resurgence in growth. Our pharma and polymer businesses are performing well, coupled with recovery in the Agrochemical segment. The USA and Japan markets have shown encouraging trends for Anupam Rasayan."

He further added, "During Q1 FY26, total exports accounted for 58% of the total revenue from operations. With the two new agreements signed with Japanese and US-based multinational companies, our order book now stands at ₹14,646.00 crore, reflecting the strong growth momentum in our business."

Business Expansion and Future Outlook

Anupam Rasayan has added one new product in Q1 FY26, taking its total product count to 80. The company's diverse product portfolio caters to various sectors, including agrochemicals, personal care, and pharmaceuticals.

The company's order book of ₹14,646.00 crore demonstrates strong future growth potential and reflects the confidence of global clients in Anupam Rasayan's capabilities.

As Anupam Rasayan continues to expand its long-term contracts, invest in eco-friendly processes, and deliver strong financial results, it is well-positioned to capitalize on the growing demand for specialty chemicals in both domestic and international markets.